162 related articles for article (PubMed ID: 11416232)
1. Height, bone mineral density and bone markers in congenital adrenal hyperplasia.
Paganini C; Radetti G; Livieri C; Braga V; Migliavacca D; Adami S
Horm Res; 2000; 54(4):164-8. PubMed ID: 11416232
[TBL] [Abstract][Full Text] [Related]
2. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I; Kanaka-Gantenbein Ch; Voutetakis A; Maniati-Christidi M; Dacou-Voutetakis C
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[TBL] [Abstract][Full Text] [Related]
3. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G; Sólyom J; Battelino T; Lebl J; Pribilincová Z; Hauspie R; Kovács J; Waldhauser F; Frisch H;
Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.
Gussinyé M; Carrascosa A; Potau N; Enrubia M; Vicens-Calvet E; Ibáñez L; Yeste D
Pediatrics; 1997 Oct; 100(4):671-4. PubMed ID: 9310523
[TBL] [Abstract][Full Text] [Related]
5. Altered bone mineral density in patients with complete androgen insensitivity syndrome.
Bertelloni S; Baroncelli GI; Federico G; Cappa M; Lala R; Saggese G
Horm Res; 1998; 50(6):309-14. PubMed ID: 9973670
[TBL] [Abstract][Full Text] [Related]
6. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
[TBL] [Abstract][Full Text] [Related]
7. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W; Bechtold S; Schmidt H; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[TBL] [Abstract][Full Text] [Related]
8. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
[TBL] [Abstract][Full Text] [Related]
9. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density.
de Almeida Freire PO; de Lemos-Marini SH; Maciel-Guerra AT; Morcillo AM; Matias Baptista MT; de Mello MP; Guerra G
J Bone Miner Metab; 2003; 21(6):396-401. PubMed ID: 14586796
[TBL] [Abstract][Full Text] [Related]
10. Effect of puberty on the relationship between bone markers of turnover and bone mineral density in Turner's syndrome.
Gallicchio CT; Figueiredo-Alves ST; Prendin Tórtora R; Mendonça LM; Farias ML; Guimarães MM
Horm Res; 2004; 61(4):193-9. PubMed ID: 14752210
[TBL] [Abstract][Full Text] [Related]
11. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P; Riche B; Pichot E; David M; Roy P; Tardy V; Kassai B; Gaillard S; Bernoux D; Morel Y; Chatelain P; Nicolino M; Cornu C;
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1379-1388. PubMed ID: 27852974
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[TBL] [Abstract][Full Text] [Related]
13. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W; Schwarz HP
Horm Res Paediatr; 2011; 75(4):264-8. PubMed ID: 21196707
[TBL] [Abstract][Full Text] [Related]
14. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM; Addo OY; Kyllo J; Gonzalez-Bolanos MT; Ltief AM; Pittock S; Himes JH; Miller BS; Sarafoglou K
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral status, bone turnover markers and vitamin D status in children with congenital adrenal hyperplasia.
Okten A; Cakir M; Makuloglu M
Minerva Endocrinol; 2012 Sep; 37(3):275-82. PubMed ID: 22766894
[TBL] [Abstract][Full Text] [Related]
16. Volumetric bone mineral density in normal subjects, aged 5-27 years.
Lu PW; Cowell CT; LLoyd-Jones SA; Briody JN; Howman-Giles R
J Clin Endocrinol Metab; 1996 Apr; 81(4):1586-90. PubMed ID: 8636372
[TBL] [Abstract][Full Text] [Related]
17. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
[TBL] [Abstract][Full Text] [Related]
18. Effects of projective bone area size of the spine on bone density and the diagnosis of osteoporosis in healthy pre-menopausal women in China.
Wu XP; Liao EY; Dai RC; Luo XH; Zhang H
Br J Radiol; 2003 Jul; 76(907):452-8. PubMed ID: 12857704
[TBL] [Abstract][Full Text] [Related]
19. The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia.
Girgis R; Winter JS
J Clin Endocrinol Metab; 1997 Dec; 82(12):3926-9. PubMed ID: 9398689
[TBL] [Abstract][Full Text] [Related]
20. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
